CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $145 | -79.7% | 4,556 | -84.5% | 0.00% | -87.5% |
| Q1 2023 | $716 | +56.7% | 29,354 | +102.4% | 0.01% | +33.3% |
| Q4 2022 | $457 | -99.8% | 14,505 | +41.7% | 0.01% | +50.0% |
| Q3 2022 | $289,000 | -44.4% | 10,234 | -48.0% | 0.00% | -33.3% |
| Q2 2022 | $520,000 | +102.3% | 19,671 | +148.6% | 0.01% | +500.0% |
| Q4 2021 | $257,000 | -65.3% | 7,913 | -68.4% | 0.00% | -66.7% |
| Q3 2021 | $740,000 | -64.7% | 25,068 | -69.3% | 0.00% | -70.0% |
| Q2 2021 | $2,094,000 | – | 81,739 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |